16/04/2014 10:02:12 Free Membership Login

   

Ariad

Visual Financials
Company Name: Ariad Pharmaceuticals
Ticker Symbol: ARIA
WWW Address: http://www.ariad.com
CEO: Harvey Berger
No. of Employees: 300
Common Issue Type: CS
Business Description:Ariad Pharmaceuticals Inc is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 6.7499 Up 0.0599 6.74 6.75 6.74 7.05 6.23 564241
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,253.2 185.7 0.82 -1.47 0.00 -4.9 0.0 23.00 - 2.15
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close6.69$
PE Ratio - LTM-4.9
Market Capitalisation1,253.2mil
Latest Shares Outstanding185.7mil
Earnings pS (EPS)-1.47$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee1,860$
Effective Tax Rate0.0%
Float178.8mil
Float as % of Shares Outstanding96.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.00$
Cash pS-1.18$
Book-Value pS1.36$
Tangible Book-Value pS0.00$
Cash Flow pS0.00$
Free Cash Flow pS0.00$
KEY FIGURES (LTM): Price info
Price/Book Ratio5.23
Price/Tangible Book Ratio0.00
Price/Cash Flow-6.0
Price/Free Cash Flow-5.8
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----3.8-312,775,81828,502,870
4 Weeks8.726.238.35-15.9-1412,306,027258,426,573
13 Weeks9.836.236.527.7618,770,5531,220,085,950
26 Weeks9.832.154.0274.66622,494,4302,834,298,263
52 Weeks23.002.1517.83-60.6-7813,426,9493,397,018,339
YTD9.836.23--3.3-419,321,3681,391,138,539
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
7.137.367.987.5410.730.821.21
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue-13.442.1-61.84
Income0.000.00.00
Dividend0.000.00.00
Capital Spending1.79NA12.09
R&D25.20NA33.45
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %7880.27880.2-97.8
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $-0.01-0.01-0.41
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio66.31
Current Ratio3.4
Quick Ratio (Acid Test)3.4
Liquidity Ratio (Cash)3.36
Receivables Turnover8.3
Average Collection Period43
Working Capital/Equity105.9
Working Capital pS0.72
Cash-Flow pS-1.27
Free Cash-Flow pS-0.95
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio6.71
Financial Leverage Ratio (Assets/Equity)1.6
Debt Ratio37.4
Total Debt/Equity (Gearing Ratio)0.10
LT Debt/Equity0.08
LT Debt/Capital Invested15.2
LT Debt/Total Liabilities13.5
Interest Cover0.0
Interest/Capital Invested0.15
 
VALUATION RATIOS
MULTIPLES
PQ Ratio-
Tobin's Q Ratio7.37
Current P/E Ratio - LTM-4.90
Enterprise Value (EV)/EBITDA-6.00
Enterprise Value (EV)/Free Cash Flow-7.33
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM5.23
Price/Cash Flow Ratio-6.0
Price/Free Cash Flow Ratio - LTM-5.8
Price/Sales Ratio481.88
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.05
Current Liabilities pS0.29
Tangible Book Value pS - LTM0.00
Book Value pS - LTM1.36
Capital Invested pS0.66
Cash pS - LTM-1.18
Cash Flow pS - LTM0.00
Free Cash Flow pS - LTM0.00
Earnings pS (EPS)-1.47
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-28,447.67
Free Cash Flow Margin 5YEAR AVG-6,024.44
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity0.00
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)-181.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.-146.9
Assets Productivity0.00
Return on Assets (ROA)-122.6
Return on Assets (ROA) - 5YEAR AVRG.-54.4
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.0.0
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle65
Revenue per Employee1,860
Net Income per Employee-736,240
Average Collection Period65
Receivables Turnover8.3
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales1,481.54
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.05
Total Assets Turnover0.0
Revenue per $ Cash0.00
Revenue per $ Plant0.07
Revenue per $ Common Equity0.00
Revenue per $ Capital Invested0.00
Selling, General & Adm/tive (SG&A) as % of Revenue10915.6
SG&A Expense as % of Revenue - 5YEAR AVRG.66.5
Research & Devlopment (R&D) as % of Revenue25933.5
R&D Expense as % of Revenue - 5YEAR AVRG.25933.5

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq aria140416 10:02